Tested Applications
| Positive WB detected in | MCF-7 cells |
| Positive IF/ICC detected in | HEK-293 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
24486-1-AP targets OTUD6A in WB, IHC, IF/ICC, IP, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag21639 Product name: Recombinant human OTUD6A protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-146 aa of BC137356 Sequence: MDDPKSEQQRILRRHQRERQELQAQIRSLKNSVPKTDKTKRKQLLQDVARMEAEMAQKHRQELEKFQDDSSIESVVEDLAKMNLENRPPRSSKAHRKRERMESEERERQESIFQAEMSEHLAGFKREEEEKLAAILGARGLEMKAI Predict reactive species |
| Full Name | OTU domain containing 6A |
| Calculated Molecular Weight | 288 aa, 33 kDa |
| Observed Molecular Weight | 33 kDa |
| GenBank Accession Number | BC137356 |
| Gene Symbol | OTUD6A |
| Gene ID (NCBI) | 139562 |
| RRID | AB_2879567 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q7L8S5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for OTUD6A antibody 24486-1-AP | Download protocol |
| WB protocol for OTUD6A antibody 24486-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The OTUD6A Polyclonal antibody (Cat# 24486-1-AP) has 14 citations. These appear in journals including Molecular Cancer, Advanced Science, Cell Death & Differentiation, Cell Death & Disease, Nature Structural & Molecular Biology, Oncogene, International Journal of Oncology, Communications Biology, International Journal of Molecular Sciences, American Journal of Physiology, BBA Molecular Basis of Disease, Molecular Oncology, Viruses, and FEBS Letters. Research fields span cancer biology (breast, bladder, cervical, prostate, colon), deubiquitination mechanisms, chemoresistance, mitochondrial function, cardiac inflammation, kidney injury, and innate immune regulation.
| Species | Application | Title |
|---|---|---|
Mol Cancer Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance | ||
Adv Sci (Weinh) OTUD6A-Mediated Deubiquitination of PRDX1 Protects Against Oral Ulcer by Restoring Mitochondrial Function. | ||
Cell Death Differ Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy. | ||
Cell Death Dis PRDM1 restricts bladder cancer progression and enhances chemosensitivity by suppressing OTUD6A-mediated deubiquitination of CDC6. | ||
Nat Struct Mol Biol TRIM21 and OTUD6A orchestrate AKT K27-linked atypical ubiquitination to modulate cancer chemoresistance.
| ||
Oncogene OTUD6A promotes de novo pyrimidine synthesis by deubiquitinating and stabilizing CAD in cervical cancer. |



